Interestingly, LH2 is a novel regulator to promote the aerobic glycolysis and tumor progression in the colorectal cancer by upregulating hexokinase 2 (Du et al., 2020), as LH2 is regulated by HIF-1α, which may mediate the aerobic glycolysis. The gene discussed is HK2; the disease is neoplasm.